192 related articles for article (PubMed ID: 18288635)
41. The cooperation of CREB and NFAT is required for PTHrP-induced RANKL expression in mouse osteoblastic cells.
Park HJ; Baek K; Baek JH; Kim HR
J Cell Physiol; 2015 Mar; 230(3):667-79. PubMed ID: 25187507
[TBL] [Abstract][Full Text] [Related]
42. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
[TBL] [Abstract][Full Text] [Related]
43. Transcriptional regulation of mouse mu opioid receptor gene by PU.1.
Hwang CK; Kim CS; Choi HS; McKercher SR; Loh HH
J Biol Chem; 2004 May; 279(19):19764-74. PubMed ID: 14998994
[TBL] [Abstract][Full Text] [Related]
44. Activation of protein kinase C accelerates murine osteoclastogenesis partly via transactivation of RANK gene through functional AP-1 responsive element in RANK gene promoter.
Kitazawa R; Kinto-Shibahara S; Haraguchi R; Kohara Y; Kitazawa S
Biochem Biophys Res Commun; 2019 Jul; 515(2):268-274. PubMed ID: 31146918
[TBL] [Abstract][Full Text] [Related]
45. Activation of the beta myosin heavy chain promoter by MEF-2D, MyoD, p300, and the calcineurin/NFATc1 pathway.
Meissner JD; Umeda PK; Chang KC; Gros G; Scheibe RJ
J Cell Physiol; 2007 Apr; 211(1):138-48. PubMed ID: 17111365
[TBL] [Abstract][Full Text] [Related]
46. Critical Role of Transcription Factor PU.1 in the Function of the OX40L/TNFSF4 Promoter in Dendritic Cells.
Yashiro T; Hara M; Ogawa H; Okumura K; Nishiyama C
Sci Rep; 2016 Oct; 6():34825. PubMed ID: 27708417
[TBL] [Abstract][Full Text] [Related]
47. The small molecule harmine regulates NFATc1 and Id2 expression in osteoclast progenitor cells.
Egusa H; Doi M; Saeki M; Fukuyasu S; Akashi Y; Yokota Y; Yatani H; Kamisaki Y
Bone; 2011 Aug; 49(2):264-74. PubMed ID: 21504804
[TBL] [Abstract][Full Text] [Related]
48. Stimuli and Relevant Signaling Cascades for NFATc1 in Bone Cell Homeostasis: Friend or Foe?
Zhang Z; Wen H; Yang X; Zhang K; He B; Zhang X; Kong L
Curr Stem Cell Res Ther; 2019; 14(3):239-243. PubMed ID: 30516111
[TBL] [Abstract][Full Text] [Related]
49. Intracellular HMGB1 transactivates the human IL1B gene promoter through association with an Ets transcription factor PU.1.
Mouri F; Tsukada J; Mizobe T; Higashi T; Yoshida Y; Minami Y; Izumi H; Kominato Y; Kohno K; Tanaka Y
Eur J Haematol; 2008 Jan; 80(1):10-9. PubMed ID: 18173740
[TBL] [Abstract][Full Text] [Related]
50. PU.1 is a lineage-specific regulator of tyrosine phosphatase CD45.
Anderson KL; Nelson SL; Perkin HB; Smith KA; Klemsz MJ; Torbett BE
J Biol Chem; 2001 Mar; 276(10):7637-42. PubMed ID: 11114304
[TBL] [Abstract][Full Text] [Related]
51. Sophorae Flos extract inhibits RANKL-induced osteoclast differentiation by suppressing the NF-κB/NFATc1 pathway in mouse bone marrow cells.
Kim JM; Lee JH; Lee GS; Noh EM; Song HK; Gu DR; Kim SC; Lee SH; Kwon KB; Lee YR
BMC Complement Altern Med; 2017 Mar; 17(1):164. PubMed ID: 28335757
[TBL] [Abstract][Full Text] [Related]
52. Transcriptional control of Pactolus: evidence of a negative control region and comparison with its evolutionary paralogue, CD18 (beta2 integrin).
Hale JS; Dahlem TJ; Margraf RL; Debnath I; Weis JJ; Weis JH
J Leukoc Biol; 2006 Aug; 80(2):383-98. PubMed ID: 16735694
[TBL] [Abstract][Full Text] [Related]
53. HSP90 inhibitors enhance differentiation and MITF (microphthalmia transcription factor) activity in osteoclast progenitors.
van der Kraan AG; Chai RC; Singh PP; Lang BJ; Xu J; Gillespie MT; Price JT; Quinn JM
Biochem J; 2013 Apr; 451(2):235-44. PubMed ID: 23379601
[TBL] [Abstract][Full Text] [Related]
54. Regulatory mechanism of NFATc1 in RANKL-induced osteoclast activation.
Song I; Kim JH; Kim K; Jin HM; Youn BU; Kim N
FEBS Lett; 2009 Jul; 583(14):2435-40. PubMed ID: 19576893
[TBL] [Abstract][Full Text] [Related]
55. PU.1 negatively regulates the CD11c integrin gene promoter through recognition of the major transcriptional start site.
López-Rodríguez C; Corbí AL
Eur J Immunol; 1997 Aug; 27(8):1843-7. PubMed ID: 9295016
[TBL] [Abstract][Full Text] [Related]
56. A two-step, PU.1-dependent mechanism for developmentally regulated chromatin remodeling and transcription of the c-fms gene.
Krysinska H; Hoogenkamp M; Ingram R; Wilson N; Tagoh H; Laslo P; Singh H; Bonifer C
Mol Cell Biol; 2007 Feb; 27(3):878-87. PubMed ID: 17116688
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of receptor activator of nuclear factor-κB ligand- or lipopolysaccharide-induced osteoclast formation by conophylline through downregulation of CREB.
Koide N; Kondo Y; Odkhuu E; Ulziisaikhan J; Ukaji T; Yokochi T; Umezawa K
Immunol Lett; 2014 Sep; 161(1):31-7. PubMed ID: 24792671
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclast formation by pyrroloquinoline quinine (PQQ).
Odkhuu E; Koide N; Haque A; Tsolmongyn B; Naiki Y; Hashimoto S; Komatsu T; Yoshida T; Yokochi T
Immunol Lett; 2012 Feb; 142(1-2):34-40. PubMed ID: 22193059
[TBL] [Abstract][Full Text] [Related]
59. 25-hydroxycholesterol promotes RANKL-induced osteoclastogenesis through coordinating NFATc1 and Sp1 complex in the transcription of miR-139-5p.
Zhang L; Lv Y; Xian G; Lin Y
Biochem Biophys Res Commun; 2017 Apr; 485(4):736-741. PubMed ID: 28257846
[TBL] [Abstract][Full Text] [Related]
60. TNF Induction of NF-κB RelB Enhances RANKL-Induced Osteoclastogenesis by Promoting Inflammatory Macrophage Differentiation but also Limits It through Suppression of NFATc1 Expression.
Zhao Z; Hou X; Yin X; Li Y; Duan R; Boyce BF; Yao Z
PLoS One; 2015; 10(8):e0135728. PubMed ID: 26287732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
